Red Light Therapy for Arterial restenosis
In a randomized trial, intravascular PBM during percutaneous coronary intervention had an insignificant effect on restenosis rate (15.0% vs 32.4%) (Derkacz et al. 2010). In rabbits, nonablative near-infrared laser has shown protective effects against neointimal hyperplasia after percutaneous transluminal coronary angioplasty (PTCA) (Kipshidze et al. 2001). In pigs, PBM has been reported to decrease neointimal hyperplasia after stenting (De Scheerder et al. 1998, De Scheerder et al. 2001).
Evidence Summary
🎲 1 human RCT 📄 4 human non-RCTs 📄 1 case series 🐁 4 animal studies (pig, rabbit) 🧪 1 cell culture study
Related Conditions in Cardiology and hematology
Research Basis
This content is informed by 47+ published peer-reviewed studies on photobiomodulation.
RedLightOS Research Team
Photobiomodulation Research
The RedLightOS team reviews over 9,500 published photobiomodulation studies to deliver evidence-based red light therapy guidance.
Reviewed by RedLightOS Research Team. Last reviewed: . Based on published photobiomodulation research. For educational purposes only — not a substitute for professional medical advice. See our methodology.
Medical Disclaimer: This content is for informational and educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Red light therapy devices are wellness devices and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary.